The Therapeutic Alliance's Moderating Role on the Negative Relationship Between Dread of Ego Dissolution and Changes in Depression Symptom Severity in Psilocybin-Assisted Therapy for Treatment-Resistant Depression: A Secondary Analysis of the PsiDeR Trial.
Abstract
This project is a secondary analysis of data from Psilocybin in Depression Resistant to Standard Treatments (PsiDeR) study, a phase II, randomised, placebo-controlled clinical trial where participants with treatment resistant depression received either 25 mg of psilocybin or a placebo alongside psychotherapy. This research seeks to determine whether the therapeutic alliance, measured by the Scale to Assess the Therapeutic Relationship-Patient/Clinician (STAR-P/C), moderates the relationship between the dread of ego dissolution subscale of the 5-Dimension Altered State of Consciousness (5D-ASC-DED) and treatment-related outcomes of depression symptom severity, measured by Montgomery–Åsberg Depression Rating Scale (MADRS).
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.